Your browser doesn't support javascript.
loading
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A; Foukakis, T; Moebus, V; Greil, R; Bengtsson, N-O; Steger, G G; Untch, M; Johansson, H; Hellström, M; Malmström, P; Gnant, M; Loibl, S; Bergh, J.
Afiliación
  • Matikas A; Department of Oncology/Pathology, Karolinska Institutet, Stockholm; Breast Center, Karolinska University Hospital, Stockholm, Sweden. Electronic address: alexios.matikas@ki.se.
  • Foukakis T; Department of Oncology/Pathology, Karolinska Institutet, Stockholm; Breast Center, Karolinska University Hospital, Stockholm, Sweden.
  • Moebus V; Department of Gynecology and Obstetrics, Klinikum Frankfurt Höchst, Academic Hospital Goethe University, Frankfurt, Germany.
  • Greil R; IIIrd Medical Department, Paracelcus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria.
  • Bengtsson NO; University Hospital Umeå, Umeå, Sweden.
  • Steger GG; Medical Oncology, Medical University, Vienna; Gaston H. Glock Research Center, Medical University, Vienna, Austria.
  • Untch M; Department of Obstetrics and Gynecology, Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Johansson H; Breast Center, Karolinska University Hospital, Stockholm, Sweden.
  • Hellström M; Breast Center, Karolinska University Hospital, Stockholm, Sweden.
  • Malmström P; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Gnant M; Gaston H. Glock Research Center, Medical University, Vienna, Austria; Department of Surgery, Medical University Vienna, Vienna, Austria.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Bergh J; Department of Oncology/Pathology, Karolinska Institutet, Stockholm; Breast Center, Karolinska University Hospital, Stockholm, Sweden.
Ann Oncol ; 30(1): 109-114, 2019 01 01.
Article en En | MEDLINE | ID: mdl-30357310
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Enfermedades Hematológicas / Obesidad Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Enfermedades Hematológicas / Obesidad Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article